Overview
Ibogaine treatment for hockey players currently exists only as off‑label, overseas, highly experimental use, mostly in small numbers of retired players seeking help for post‑career substance use, depression, PTSD, pain, and probable TBI/CTE‑related symptoms. There are no controlled clinical trials specifically in hockey players yet; what exists are case‑level reports e.g., Ales Hemsky, extrapolation from high‑contact sports NFL, UFC and special‑forces veterans, plus broader ibogaine addiction/TBI literature.
Below is a detailed research dossier organized as: 1. Context: why hockey players are looking at ibogaine 2.
Documented cases and programs involving hockey players 3. What the TBI/PTSD ibogaine data show veteran & athlete analogs 4.[1]
Addiction‑focused ibogaine evidence relevant to players 5. Mechanisms: how ibogaine might help brain‑injured hockey players 6.[2]
Safety, especially cardiac risk, and protocols used in athletes 7. Legal status and where players are actually going 8.[3]
Research findings
e/alcohol use remission after a single ibogaine‑centered episode. - The article does not specify dose, mg/kg, or standardized outcome scales for Hemsky, but Ambio reports using a protocol similar to that in the Stanford TBI study see below.
1 Other hockey players inferred but not named - The Los Angeles Times notes that around a dozen retired contact‑sports athletes NFL, UFC, hockey have been treated at Ambio, naming Hemsky explicitly as a retired hockey player, but not publicly identifying other hockey players by name. 1 As of mid‑2026: - There are no peer‑reviewed case series specifically “ibogaine in hockey players”.[1]
- Available reports are journalistic and describe individual players within broader athlete cohorts. Ambio’s athlete cohort more broadly Ambio Life Sciences, the Tijuana clinic collaborating with Stanford, reports: - 3,000 patients treated since opening in 2021, including about 1,000 military veterans and an unspecified number of retired contact‑sport athletes.[2]
1 - Athletes mentioned: - Brett Favre NFL, Parkinson’s symptoms temporarily eased for 3 days 1 - Keith Jardine UFC - Justin “The Big Pygmy” Wren, Kenyon “KJ” Jardine, and others depending on the article version - The clinic employs Ibogaine + magnesium + continuous cardiac monitoring, the same platform used in the Stanford Nature Medicine TBI trial. 1 Thus, retired hockey players seeking ibogaine typically: - Travel to Tijuana or other Mexican/Canadian clinics - Are treated alongside NFL/UFC athletes and veterans - Receive a protocol adapted from addiction‑detox levels 10–20 mg/kg but optimized for TBI/psychiatric symptoms with stringent cardiac precautions --- 3.[3]
TBI/PTSD evidence most relevant to hockey players Although there are no hockey‑specific trials, the closest analog is the Stanford Medicine ibogaine TBI/PTSD study in special forces veterans, published in Nature Medicine in early 2024. Stanford / Ambio TBI Study Nature Medicine 2024 - Citation & design - Williams NR, Kratter IH, et al., Nature Medicine 2024.
Safety considerations
tration, information processing, memory, and impulsivity on formal neuropsychological tests. 2 These are extremely large effect sizes for a single‑session intervention, though the study is uncontrolled and short‑follow‑up.[1]
- Adverse events / safety - No serious adverse events reported. 2 - No clinically significant arrhythmias or cardiac events, despite careful monitoring and pre‑treatment magnesium.[2]
1 - Typical side‑effects: headache and nausea during the acute psychedelic phase. 2 - Relevance to hockey players - UCLA neurologist Kevin Bickart, who specializes in brain injury in athletes, commented that this veteran cohort is “a strong analogue for retired professional athletes from high‑contact sports like football or hockey who are now dealing with persistent cognitive and emotional difficulties.” 1 - Penn Medicine TBI center director Ramon Diaz‑Arrastia called ibogaine “one of the more promising compounds” for TBI, while emphasizing the need for more data.[3]
1 Given that retired hockey players have: - Similar or higher levels of repetitive head trauma than some military cohorts - Nearly identical psychiatric and cognitive symptom profiles …it is scientifically reasonable to view this study as a proof‑of‑concept model for what ibogaine might do in retired hockey players, while stressing that it does not yet constitute sport‑specific evidence. 5‑MeO‑DMT adjuncts Some brain‑injury programs including those discussed in the New York Times and summarized by Concussion Alliance use ibogaine followed by 5‑MeO‑DMT: - Veterans receive oral ibogaine at a Tijuana clinic, followed by a separate 5‑MeO‑DMT session; psychotherapy integrates both experiences.
3 - Many report dramatic improvements in sleep, concentration, emotional control, memory, depression, and substance use after a single ibogaine + 5‑MeO‑DMT course. 3 Some athlete‑oriented TBI programs mirror this model.
Legal and clinical context
striatal circuits implicated in depression, impulse control, and addiction - Cognitive recovery in areas like processing speed and working memory Functional and neuropsychiatric symptom relief Stanford psychiatrist Nolan Williams is quoted: “No other drug has ever been able to alleviate the functional and neuropsychiatric symptoms of traumatic brain injury ” to this degree. 1 This comment underscores that: - For chronic TBI/CTE symptoms—typical in retired hockey players—available pharmacological options SSRIs, stimulants, etc.[2]
- A single high‑impact, plasticity‑modulating session would be paradigm‑shifting if controlled trials confirm these observational findings. Psychedelic psychological mechanisms Beyond neurobiology, players often describe: - Intense autobiographical review - Confrontation with trauma, guilt, identity, and career transition - Changes in self‑narrative and behavioral intentions e.g., quitting alcohol, reconciling relationships These experiences likely contribute to enduring behavioral change even if the neurobiological contribution is uncertain.[3]
Safety and cardiac risk in athletes General ibogaine risks Across the global literature, ibogaine is associated with: - QT interval prolongation, which can precipitate torsades de pointes and sudden cardiac death in susceptible individuals - Bradycardia and hypotension - Potential neurotoxicity at very high doses mainly in animals - Gastrointestinal side effects nausea, vomiting, ataxia, insomnia, and acute anxiety Several dozen ibogaine‑associated deaths have been reported globally over three decades, often involving: - Unscreened patients with pre‑existing heart disease - Co‑use of QT‑prolonging medications e.g., References